FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2557543885> ?p ?o ?g. }

• W2557543885 abstract "Abstract Abstract 2744 Background Myeloid-derived suppressor cells (MDSCs) are cells of myeloid origin that are able to inhibit immune cells such as T cells. MDSCs have been found in many different solid tumors and the role of these cells in cancer is currently in focus since they hamper anti-tumor immune responses and thereby lead to a worse prognosis for the patients. The presence and function of MDSCs in hematological malignancies such as chronic myeloid leukemia (CML) has so far not been extensively studied. Since patients with CML have malignant immature myeloid cells in blood and bone marrow it is of interest to investigate if these cells are myeloid suppressor cells. Furthermore, the level of MDSCs in solid tumors decreases after treatment with the tyrosine kinase inhibitor (TKI) sunitinib. CML patients are treated with other TKIs such as imatinib and dasatinib and it is of interest to investigate if these have the same effect on MDSCs. Imatinib and dasatinib are intended to block bcr-abl in the tumor cells. In addition to this, these TKIs have been shown to interact with other tyrosine kinases present in immune cells. Aim The aim of the study was to investigate the presence of MDSCs and the MDSC-associated molecule Arginiase-1 in CML patients and cell lines as well as to investigate the effect of the TKIs on MDSCs in vitro. Methods Cryopreserved leukapheresis samples from newly diagnosed patients in chronic phase (n=18) from high (n=11) and low (n=7) Sokal score risk group CML patients and buffy coats from healthy controls (HC, n=21) as well as CML cell lines BV173, K562 and CML-T1 were investigated for the presence of MDSCs (CD11b+CD14-CD33+ cells) by flow cytometry. Peripheral blood mononuclear cells (PBMCs) from healthy donors were cultured in different concentrations of imatinib or dasatinib and the level of MDSCs in cultures was assessed after 2 and 4 days of culture by flow cytometry. The level of the MDSC-associated molecule Arginase-1 in cells from CML patients (n=5), controls (n=5) and CML cell lines as well as in healthy PBMCs after culture with imatinib or dasatinib was assessed by real time PCR. Results CML patients had significantly higher levels of MDSCs compared to health controls (medians 2,6% in CML and 0,8% in HC). When CML patients were divided into Sokal high and low risk groups the high risk group had higher MDSC level (median 3,6%) compared to the low risk group (median 0,8%). The level of MDSC in Sokal low risk group did not differ from the level in HCs. Arginase-1 is a molecule linked to the immune inhibitory effects of MDSCs. The mRNA expression level of Arginase-1 was higher in CML patients compared to HCs as assessed by real time PCR. When healthy PBMCs were cultured with imatinib or dasatinib for 2 to 4 days, the level of MDSCs increased in a dose dependent manner. In accordance with this, the Arginase-1 mRNA expression also increased with treatment in a dose dependent manner. All cell lines investigated had cells with the MDSC phenotype, however not all cells exhibited that phenotype. Only K562 expressed Arginase-1 and the expression increased when the cells were treated with imatinib or dasatinib. Conclusions CML have higher MDSC levels compared to healthy individuals and the level correlates to Sokal score. The level of MDSCs also correlates with mRNA expression of Arginase-1. Interestingly, treatment of healthy donor PBMCs with the TKIs imatinib or dasatinib increases the level of MDSCs in contrast to results shown with sunitinib. Disclosures: Simonsson: Novartis, BMS, Merck, Pfizer: Consultancy, Honoraria." @default.
• W2557543885 created "2016-12-08" @default.
• W2557543885 creator A5001045429 @default.
• W2557543885 creator A5010427139 @default.
• W2557543885 creator A5012035138 @default.
• W2557543885 creator A5013318211 @default.
• W2557543885 creator A5029702478 @default.
• W2557543885 creator A5063027590 @default.
• W2557543885 creator A5075849003 @default.
• W2557543885 date "2011-11-18" @default.
• W2557543885 modified "2023-09-30" @default.
• W2557543885 title "Increased Levels of Myeloid-Derived Suppressor Cells (MDSCs) in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on MDSCs in Vitro" @default.
• W2557543885 doi "https://doi.org/10.1182/blood.v118.21.2744.2744" @default.
• W2557543885 hasPublicationYear "2011" @default.
• W2557543885 type Work @default.
• W2557543885 sameAs 2557543885 @default.
• W2557543885 citedByCount "0" @default.
• W2557543885 crossrefType "journal-article" @default.
• W2557543885 hasAuthorship W2557543885A5001045429 @default.
• W2557543885 hasAuthorship W2557543885A5010427139 @default.
• W2557543885 hasAuthorship W2557543885A5012035138 @default.
• W2557543885 hasAuthorship W2557543885A5013318211 @default.
• W2557543885 hasAuthorship W2557543885A5029702478 @default.
• W2557543885 hasAuthorship W2557543885A5063027590 @default.
• W2557543885 hasAuthorship W2557543885A5075849003 @default.
• W2557543885 hasConcept C121608353 @default.
• W2557543885 hasConcept C126322002 @default.
• W2557543885 hasConcept C170493617 @default.
• W2557543885 hasConcept C179185449 @default.
• W2557543885 hasConcept C203014093 @default.
• W2557543885 hasConcept C2776960273 @default.
• W2557543885 hasConcept C2777583451 @default.
• W2557543885 hasConcept C2778461978 @default.
• W2557543885 hasConcept C2778729363 @default.
• W2557543885 hasConcept C2778820342 @default.
• W2557543885 hasConcept C2779282312 @default.
• W2557543885 hasConcept C2779490328 @default.
• W2557543885 hasConcept C2779536868 @default.
• W2557543885 hasConcept C3019892230 @default.
• W2557543885 hasConcept C42362537 @default.
• W2557543885 hasConcept C502942594 @default.
• W2557543885 hasConcept C55721878 @default.
• W2557543885 hasConcept C71924100 @default.
• W2557543885 hasConcept C8891405 @default.
• W2557543885 hasConceptScore W2557543885C121608353 @default.
• W2557543885 hasConceptScore W2557543885C126322002 @default.
• W2557543885 hasConceptScore W2557543885C170493617 @default.
• W2557543885 hasConceptScore W2557543885C179185449 @default.
• W2557543885 hasConceptScore W2557543885C203014093 @default.
• W2557543885 hasConceptScore W2557543885C2776960273 @default.
• W2557543885 hasConceptScore W2557543885C2777583451 @default.
• W2557543885 hasConceptScore W2557543885C2778461978 @default.
• W2557543885 hasConceptScore W2557543885C2778729363 @default.
• W2557543885 hasConceptScore W2557543885C2778820342 @default.
• W2557543885 hasConceptScore W2557543885C2779282312 @default.
• W2557543885 hasConceptScore W2557543885C2779490328 @default.
• W2557543885 hasConceptScore W2557543885C2779536868 @default.
• W2557543885 hasConceptScore W2557543885C3019892230 @default.
• W2557543885 hasConceptScore W2557543885C42362537 @default.
• W2557543885 hasConceptScore W2557543885C502942594 @default.
• W2557543885 hasConceptScore W2557543885C55721878 @default.
• W2557543885 hasConceptScore W2557543885C71924100 @default.
• W2557543885 hasConceptScore W2557543885C8891405 @default.
• W2557543885 hasLocation W25575438851 @default.
• W2557543885 hasOpenAccess W2557543885 @default.
• W2557543885 hasPrimaryLocation W25575438851 @default.
• W2557543885 hasRelatedWork W1589700409 @default.
• W2557543885 hasRelatedWork W2008717037 @default.
• W2557543885 hasRelatedWork W2044781236 @default.
• W2557543885 hasRelatedWork W2518390669 @default.
• W2557543885 hasRelatedWork W2535034294 @default.
• W2557543885 hasRelatedWork W254666282 @default.
• W2557543885 hasRelatedWork W2555020818 @default.
• W2557543885 hasRelatedWork W2579201588 @default.
• W2557543885 hasRelatedWork W2591685873 @default.
• W2557543885 hasRelatedWork W2621376045 @default.
• W2557543885 hasRelatedWork W274242853 @default.
• W2557543885 hasRelatedWork W2772113180 @default.
• W2557543885 hasRelatedWork W2977626454 @default.
• W2557543885 hasRelatedWork W2979351149 @default.
• W2557543885 hasRelatedWork W2980120637 @default.
• W2557543885 hasRelatedWork W2980282187 @default.
• W2557543885 hasRelatedWork W3030321340 @default.
• W2557543885 hasRelatedWork W3047316303 @default.
• W2557543885 hasRelatedWork W3180721253 @default.
• W2557543885 hasRelatedWork W3213561768 @default.
• W2557543885 isParatext "false" @default.
• W2557543885 isRetracted "false" @default.
• W2557543885 magId "2557543885" @default.
• W2557543885 workType "article" @default.